MD

Marguerite Davis

Senior Clinical Data Analyst, Foresite Capital

Lewes, Delaware

Invests in

Work Experience

  • Senior Clinical Data Analyst

    2024

    Identifying and tracking milestones and financial inflection points for portfolio companies and prospective investments, proactively monitor competitive intelligence, early adopter of prospective novel technology applications

  • Clinical Data Analyst

    2022 - 2024

2019 - 2022

  • Director R & D Operations

    2019 - 2022

  • Senior Project Manager, Gene Therapy Program

    2017 - 2019

  • Project Manager, Gene Therapy Program

    2014 - 2017

  • Postdoctoral Research Associate, Translational Research on Pain Therapies

    2012 - 2014

    • Developed methods for therapeutic delivery of miRNAs and exosomes to animal models of pain • Authored a translational research study on changes in exosomal transcriptome in patients with complex regional pain syndrome (CRPS) and in animal models of inflammatory pain • Verified miRNA regulation of inflammatory mRNAs in vitro • Mentored undergraduate and graduate students, managed ordering and protocol development

  • Graduate Research Assistant, Biochemistry

    2007 - 2012

    The second half of my Ph.D. research focused on mechanisms of translational regulation and regeneration in adult rodent sensory neurons. I transitioned into the lab of Dr. Jeffery Twiss at Nemours/A.I. duPont Hospital, but kept my affiliation with University of Delaware's Chemistry and BIochemistry Department. • Quantified localization and colocalization between mRNA degradation proteins in rodent peripheral axons • Measured the half-life of localized axonal mRNAs in response to neurotrophic factors after axotomy

  • Graduate research assistant, Biochemistry

    2003 - 2007

    My graduate studies began in the lab of Dr. Mueller, who relocated his lab to University of Louisville in 2007. My initial training was in mechanistic enzymology and I developed a strong foundation in protein biochemistry. • Published the kinetic and spectrophotometric characterization of enzyme: fluorinated tRNA inhibitor adducts • Resolved a discrepancy between a radiometric and spectrophotometric measurement of a tritium-labeled RNA substrate that helped the lab perform experiments with an increased accuracy and incorporate quality control procedures